List of Excipients in API hydrocortisone acetate pramoxine hcl
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing hydrocortisone acetate pramoxine hcl
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Padagis Israel Pharmaceuticals Ltd | hydrocortisone acetate pramoxine hcl | 45802-144 | CETYL ALCOHOL |
| Padagis Israel Pharmaceuticals Ltd | hydrocortisone acetate pramoxine hcl | 45802-144 | ISOPROPYL PALMITATE |
| Padagis Israel Pharmaceuticals Ltd | hydrocortisone acetate pramoxine hcl | 45802-144 | POLYOXYL 40 STEARATE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for hydrocortisone acetate pramoxine hcl
Excipient focus: CETYL ALCOHOL
hydrocortisone acetate pramoxine hcl drug variants containing CETYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Padagis Israel Pharmaceuticals Ltd | hydrocortisone acetate pramoxine hcl | 45802-144 |
| Bryant Ranch Prepack | hydrocortisone acetate pramoxine hcl | 63629-8669 |
| Bryant Ranch Prepack | hydrocortisone acetate pramoxine hcl | 72162-1399 |
| >Company | >Ingredient | >NDC |
hydrocortisone acetate pramoxine hcl drug variants not containing CETYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL PALMITATE
hydrocortisone acetate pramoxine hcl drug variants containing ISOPROPYL PALMITATE
| Company | Ingredient | NDC |
|---|---|---|
| Padagis Israel Pharmaceuticals Ltd | hydrocortisone acetate pramoxine hcl | 45802-144 |
| Bryant Ranch Prepack | hydrocortisone acetate pramoxine hcl | 63629-8669 |
| Bryant Ranch Prepack | hydrocortisone acetate pramoxine hcl | 72162-1399 |
| >Company | >Ingredient | >NDC |
hydrocortisone acetate pramoxine hcl drug variants not containing ISOPROPYL PALMITATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYOXYL 40 STEARATE
hydrocortisone acetate pramoxine hcl drug variants containing POLYOXYL 40 STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Padagis Israel Pharmaceuticals Ltd | hydrocortisone acetate pramoxine hcl | 45802-144 |
| Bryant Ranch Prepack | hydrocortisone acetate pramoxine hcl | 63629-8669 |
| Bryant Ranch Prepack | hydrocortisone acetate pramoxine hcl | 72162-1399 |
| >Company | >Ingredient | >NDC |
hydrocortisone acetate pramoxine hcl drug variants not containing POLYOXYL 40 STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM SORBATE
hydrocortisone acetate pramoxine hcl drug variants containing POTASSIUM SORBATE
| Company | Ingredient | NDC |
|---|---|---|
| Padagis Israel Pharmaceuticals Ltd | hydrocortisone acetate pramoxine hcl | 45802-144 |
| Bryant Ranch Prepack | hydrocortisone acetate pramoxine hcl | 63629-8669 |
| Bryant Ranch Prepack | hydrocortisone acetate pramoxine hcl | 72162-1399 |
| >Company | >Ingredient | >NDC |
hydrocortisone acetate pramoxine hcl drug variants not containing POTASSIUM SORBATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
hydrocortisone acetate pramoxine hcl drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Padagis Israel Pharmaceuticals Ltd | hydrocortisone acetate pramoxine hcl | 45802-144 |
| Bryant Ranch Prepack | hydrocortisone acetate pramoxine hcl | 63629-8669 |
| Bryant Ranch Prepack | hydrocortisone acetate pramoxine hcl | 72162-1399 |
| >Company | >Ingredient | >NDC |
hydrocortisone acetate pramoxine hcl drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SORBIC ACID
hydrocortisone acetate pramoxine hcl drug variants containing SORBIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Padagis Israel Pharmaceuticals Ltd | hydrocortisone acetate pramoxine hcl | 45802-144 |
| Bryant Ranch Prepack | hydrocortisone acetate pramoxine hcl | 63629-8669 |
| Bryant Ranch Prepack | hydrocortisone acetate pramoxine hcl | 72162-1399 |
| >Company | >Ingredient | >NDC |
hydrocortisone acetate pramoxine hcl drug variants not containing SORBIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STEARIC ACID
hydrocortisone acetate pramoxine hcl drug variants containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Padagis Israel Pharmaceuticals Ltd | hydrocortisone acetate pramoxine hcl | 45802-144 |
| Bryant Ranch Prepack | hydrocortisone acetate pramoxine hcl | 63629-8669 |
| Bryant Ranch Prepack | hydrocortisone acetate pramoxine hcl | 72162-1399 |
| >Company | >Ingredient | >NDC |
hydrocortisone acetate pramoxine hcl drug variants not containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIETHANOLAMINE LAURYL SULFATE
hydrocortisone acetate pramoxine hcl drug variants containing TRIETHANOLAMINE LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Padagis Israel Pharmaceuticals Ltd | hydrocortisone acetate pramoxine hcl | 45802-144 |
| Bryant Ranch Prepack | hydrocortisone acetate pramoxine hcl | 63629-8669 |
| Bryant Ranch Prepack | hydrocortisone acetate pramoxine hcl | 72162-1399 |
| >Company | >Ingredient | >NDC |
hydrocortisone acetate pramoxine hcl drug variants not containing TRIETHANOLAMINE LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
hydrocortisone acetate pramoxine hcl drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Padagis Israel Pharmaceuticals Ltd | hydrocortisone acetate pramoxine hcl | 45802-144 |
| Bryant Ranch Prepack | hydrocortisone acetate pramoxine hcl | 63629-8669 |
| Bryant Ranch Prepack | hydrocortisone acetate pramoxine hcl | 72162-1399 |
| >Company | >Ingredient | >NDC |
hydrocortisone acetate pramoxine hcl drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch